Reslizumab [CAS 241473-69-8]
Partner: MedChemexpress LLC
CAS No: | 241473-69-8 |
Applications: | COVID-19-immunoregulation |
MW: | N/A |
Formula: | N/A |
SMILES: | [Reslizumab] |
Purity: | 99.40 |
Description: | Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively[1][2]. |
Shipping Conditions: | Ship on cold packs |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice